Researchers from the Department of Surgical Oncology at the Institute of Medical Sciences, Banaras Hindu University (BHU), have published a landmark study titled 'Defining Surgical Excellence in Gallbladder Cancer: A Meta-Analysis Validating the 6-Node Threshold and Extended D2 Lymphadenectomy Across All T-Stages' in the European Journal of Surgical Oncology. The study aims to establish surgical guidelines and improve clinical outcomes for gallbladder cancer, particularly in high-burden regions such as northern India.
Study Leadership and Methodology
Led by Professor Manoj Pandey, in collaboration with the Health Technology Assessment in India (HTAIn) nodal centre, the study involved contributions from team members at IMS-BHU. The analysis employed systematic review and meta-analysis methods, incorporating global data published between 1999 and 2025. It is based on a comprehensive analysis of 27 international studies involving over 56,000 patients.
Key Findings
The study establishes that removal of at least six lymph nodes is a critical surgical quality benchmark significantly associated with improved survival in gallbladder cancer. It further demonstrates that the survival benefit of lymphadenectomy is consistent across all disease stages (T1b to T4). Moreover, extended lymphadenectomy (D2), which includes retropancreatic and celiac nodes, provides superior outcomes in T2 and T3 disease.
Therapeutic Benefits Beyond Staging
The findings highlight that adequate lymph node removal not only improves staging accuracy but also reduces recurrence and enhances disease-free survival. This establishes lymphadenectomy as a key therapeutic component rather than merely a diagnostic procedure. The study is particularly important because gallbladder cancer is prevalent in parts of India and often diagnosed at advanced stages.
Clinical Implications
Surgical removal remains the only curative option for gallbladder cancer, but the extent of surgery has long been debated. This study resolves a critical clinical question by demonstrating that lymphadenectomy has a direct therapeutic benefit, improving both survival and disease control. Professor Pandey emphasized, 'Our findings provide a clear, evidence-based framework for surgeons worldwide. Adequate lymph node removal should be considered essential, not optional, in gallbladder cancer surgery. It is important that in cases of suspected carcinoma of the gallbladder, a patient seek expert surgical oncology opinion and surgery performed by a surgeon with expertise in complex radical surgeries and not by a general surgeon. As a good comprehensive surgery is the only thing that offers a chance for cure.'
